Why the study?
Rotational atherectomy treats coronary artery calcification during PCI, but the safety and efficacy of combining it with cutting balloon angioplasty before stent placement required evaluation.
Does rotational atherectomy followed by cutting balloon angioplasty (ROTACUT) reduce major adverse cardiovascular events compared to rotational atherectomy with bare balloons in patients with severely calcified coronary lesions undergoing PCI?
Does rotational atherectomy followed by cutting balloon angioplasty (ROTACUT) reduce major adverse cardiovascular events compared to rotational atherectomy with bare balloons in patients with severely calcified coronary lesions undergoing PCI?
Rotational atherectomy combined with cutting balloon angioplasty (ROTACUT) demonstrates comparable clinical efficacy and procedural safety to rotational atherectomy with bare balloons in preparing severely calcified coronary lesions for stenting.
Answers are grounded in this paper and cite their sources.
Supports ROTACUT as a safe lesion-preparation strategy in severe CAC; extends mixed evidence but leaves optimal use open pending dedicated RCTs.
Background Rotational atherectomy (RA) has been proven to treat coronary artery calcification (CAC) during percutaneous coronary intervention (PCI).Purpose This study evaluates the safety and efficacy of RA followed by cutting balloon angioplasty (ROTACUT) before stent placement in CAC.Methods A systematic review and meta-analysis of randomized controlled trials and observational studies was conducted. PubMed, Web of Science, Scopus, and Cochrane were searched through January 2024. We used Stata version 17 to pool dichotomous data using risk ratio (RR) and continuous data using mean difference (MD), with a 95% confidence interval (CI).Results Eight studies with 846 patients were included. There was no significant difference between ROTACUT and RA + bare balloons in major adverse cardiovascular events (MACE) (RR:0.60; 95%CI [0.31,1.16], p = 0.13), cardiac death (RR:1.32; 95%CI [0.42,4.14], p = 0.64), target vessel revascularization (TVR) (RR:1.89; 95%CI [0.40,8.84], p = 0.42), target lesion revascularization (TLR) (RR:0.83; 95%CI [0.39,1.79], p = 0.64), procedural duration (MD:0.78; 95%CI [−4.68,6.24], p = 0.78), stent thrombosis (RR:0.81; 95%CI [0.22,2.95], p = 0.75), and any procedure-related complications (RR:0.86; 95%CI [0.42,1.75], p = 0.68).Conclusion ROTACUT and RA + bare balloons demonstrated similar efficacy and safety profiles regarding MACE, cardiac death, TVR, TLR, procedural duration, stent thrombosis, and all safety outcomes.
No takes yet. Share an insight, caveat, or question.
Altobaishat et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: